Investigating Genetic Status in Patients Presenting to Clinic

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);

• Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;

• Age 18+ years old;

• Consenting to a blood draw.

Locations
Other Locations
Canada
Parkwood Institute
RECRUITING
London
Contact Information
Primary
Sarah Jesso
cognitiveneurology@sjhc.london.on.ca
519-646-6000
Time Frame
Start Date: 2023-10-20
Estimated Completion Date: 2043-08
Participants
Target number of participants: 1000
Sponsors
Leads: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

This content was sourced from clinicaltrials.gov